Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Michael H Le"'
Autor:
Philip Vutien, Michelle Jin, Michael H Le, Pauline Nguyen, Sam Trinh, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Mindie H Nguyen
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0183851 (2017)
Treatment rates with interferon-based therapies for chronic hepatitis C have been low. Our aim was to perform a systematic review of available data to estimate the rates and barriers for antiviral therapy for chronic hepatitis C.We conducted a system
Externí odkaz:
https://doaj.org/article/4932a47af5ab41d59a14b6f9092e6bc7
Autor:
Michael H Le, Pardha Devaki, Nghiem B Ha, Dae Won Jun, Helen S Te, Ramsey C Cheung, Mindie H Nguyen
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173499 (2017)
In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and associated with higher mortality according to data from earlier National Health and Nutrition Examination Survey (NHANES) 1988-1994. Our goal was to
Externí odkaz:
https://doaj.org/article/51b0d94c4c1c4b2b8ac4203287f8e0d8
Autor:
Vy H. Nguyen, Daniel Q. Huang, Michael H. Le, Michelle Jin, Eunice Y. Lee, Linda Henry, Sanjna N. Nerurkar, Eiichi Ogawa, Khin N. Thin, Margaret L. P. Teng, Kang S. Goh, Justin C. Y. Kai, Connie Wong, Darren J. H. Tan, Le T. T. Thuy, Hoang Hai, Masaru Enomoto, Ramsey Cheung, Mindie H. Nguyen
Publikováno v:
Liver International. 43:1195-1203
Autor:
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Publikováno v:
Clinical and Molecular Hepatology. 28:841-850
Background/Aims: Due to increases in obesity and type 2 diabetes, the prevalence of nonalcoholic fatty liver disease (NAFLD) has also been increasing. Current forecast models may not include non-obese NAFLD. Here, we used the Bayesian approach to for
Autor:
Daniel Q. Huang, Dong Hyun Lee, Michael H. Le, An Le, Yee Hui Yeo, Huy N. Trinh, Mimi Chung, Vy Nguyen, Tiffani Johnson, Jian Q. Zhang, Clifford Wong, Christopher Wong, Jiayi Li, Ramsey Cheung, Mindie H. Nguyen
Publikováno v:
Digestive Diseases. 41:115-123
Background: A substantial number of patients who do not meet treatment criteria for chronic hepatitis B (CHB) later develop adverse outcomes such as cirrhosis and hepatocellular carcinoma (HCC). Our aim was to determine whether current practice guide
Autor:
Michael H. Le, David M. Le, Thomas C. Baez, Yuankai Wu, Takanori Ito, Eunice Y. Lee, KeeSeok Lee, Christopher D. Stave, Linda Henry, Scott D. Barnett, Ramsey Cheung, Mindie H. Nguyen
Publikováno v:
Journal of Hepatology.
Autor:
Linda Henry, V. H. Nguyen, Mindie H. Nguyen, Ramsey Cheung, B. Zou, Yee Hui Yeo, Michael H. Le
Publikováno v:
Journal of Internal Medicine. 289:840-850
BACKGROUND Currently, weight loss remains the main management strategy for NAFLD, but the weight loss intention and methods remain poorly characterized. METHODS We analysed data about the perception of weight status, intention and methods to lose wei
Publikováno v:
Hepatology Communications
As social distancing and strict stay‐at‐home orders have been instituted to slow the spread of coronavirus disease 2019 (COVID‐19), unintentional outcomes among those with chronic diseases including screening for the lethal hepatocellular carci
Publikováno v:
Journal of Internal Medicine. 287:711-722
Background Nonalcoholic fatty liver disease (NAFLD) is a rising global disease associated with clinical and economic burdens. Objectives We aimed to quantify NAFLD prevalence and awareness to provide stakeholders necessary information to combat NAFLD
Publikováno v:
JAMA network open. 5(2)